The Virtual CVOT Summit 2023 is organized in scientific cooperation with the Forschergruppe Diabetes e.V., the DCVD, and the EDNSG of the EASD, the PCDE, the Working Group ‘Diabetes and Heart’ of the DDG as well as the China CardioMetabolic Associaton.
Study Group on Primary Care Research in Diabetology (PCDE)
The Study Group on Primary Care Diabetes Europe (PCDE) exists to provide a focal point for primary care clinicians and their patients. Its purpose is to promote high standards of care throughout Europe. Emphasis is placed on incorporating evidence-based medicine into daily practice as well as promoting diabetes education and research in primary care.
Diabetes and Cardiovascular Disease Study Group (D&CVD)
The Diabetes and Cardiovascular Disease Study Group (D&CVD) promotes the advancement of knowledge on all aspects of Cardiovascular Disease and Diabetes through active cooperation between interested Diabetologists and other specialists, particularly Cardiologists. It works actively to establish European collaborative studies. The main aim of D&CVD Study Group is to bring together researchers in the field of cardiovascular disease in diabetes mellitus, exchange experiences in research, and promote discussions during regular meetings.
Working Group ‘Diabetes and Heart’ of the German Diabetes Society (DDG)
The Working Group `Diabetes and Heart’ of the DDG exists to promote the advancement of knowledge on all aspects of cardiovascular disease and diabetes through active cooperation between interested diabetologists and other specialists, particularly cardiologists. It works actively for the establishment of interdisciplinary cooperations for the prevention and therapy of comorbidities.
EDNSG – European Diabetic Nephropathy Study Group
The Diabetic Nephropathy Study Group of the EASD is established with the aim of assembling researchers interested in diabetic renal disease in order to study epidemiology, pathology, pathophysiology, and treatment of this complication of diabetes mellitus. The ultimate goal of the Group is to prevent the appearance or the development of kidney disease and to search for the best treatment for this condition in diabetic patients.
China CardioMetabolic Association
Forschergruppe Diabetes e.V., Munich, Germany